Hand Function Outcome After the Application of Transfer Energy Capacitive and Resistive on Post-burn Patients Presented With Carpal Tunnel Syndrome
16 de junio de 2026 actualizado por: Ahmed Abdelnaser Mohamed Mohamed Youness, Cairo University
EFFECT OF TRANSFER ENERGY CAPACITIVE AND RESISTIVE ON CARPAL TUNNEL SYNDROME POST BURN
Carpal Tunnel Syndrome (CTS) is a common entrapment neuropathy that can develop as a secondary complication following deep burns involving the hand or wrist. Post-burn CTS arises due to factors such as fibrosis, edema, and scar contracture, which may increase pressure on the median nerve within the carpal tunnel, leading to significant pain, sensory disturbances, and impaired hand function Recent studies support the effectiveness of Transfer Energy Capacitive and Resistive (TECAR ) therapy in idiopathic CTS, showing improvements in pain, symptom severity, and function, as measured by validated tools such as the Boston Carpal Tunnel Questionnaire (BCTQ) and Visual Analogue Scale (VAS).
A study reported that both TECAR and ultrasound groups showed significant symptom improvement after treatment, although ultrasound had more sustained effects on median nerve cross-sectional area at 3 months
Descripción general del estudio
Estado
Aún no reclutando
Condiciones
Descripción detallada
This study will involve 52 patients diagnosed with CTS post-burn; they will receive TECAR as an intervention.
The outcome measures include ( VAS, Arabic version of Boston Carpal Tunnel Questionnaire, and Camry Digital Handgrip Dynamometer
Tipo de estudio
Intervencionista
Inscripción (Estimado)
52
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Estudio Contacto
- Nombre: Ahmed abdelnasr Mohamed Youness, Demonstrator (TA)
- Número de teléfono: +2001553712231
- Correo electrónico: pt.ahmed.mido@gmail.com
Copia de seguridad de contactos de estudio
- Nombre: Nada Mohamed Yousef, Lecturer
- Número de teléfono: +2001002010168
- Correo electrónico: Dr.nada123.ny@gmail.com
Ubicaciones de estudio
-
-
Mansoura
-
Al Mansurah, Mansoura, Egipto, 35511
- QWAM physio clinic
-
Contacto:
- Mohamed Mohamed Abdelwahab, Supervisor
- Número de teléfono: +2001557393444
- Correo electrónico: outlast829@gmail.com
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
Acepta Voluntarios Saludables
No
Descripción
Inclusion Criteria:
- Participant is between 20 and 40 years of age.
- Diagnosed with mild to moderate carpal tunnel syndrome (CTS).
- History of an upper limb burn, with the percentage of the Total Body Surface Area (TBSA) ranging from 20% to 25%.
- Upper limb burn is diagnosed as a 2nd or 3rd-degree burn complicated with carpal tunnel syndrome.
- Carpal tunnel syndrome diagnosis is clinically confirmed using physical examination, including a positive Tinel's sign and positive Phalen's test.
- Participant provides written informed consent before enrollment.
Exclusion Criteria:
- History of double crush syndrome, cervical radiculopathy, or fibromyalgia.
- History of wrist fracture or distal radius fracture.
- Diagnosis of systemic or local diseases that contribute to peripheral neuropathy, including Diabetes Mellitus or rheumatoid arthritis (RA).
- Diagnosis of hypothyroidism, skin diseases, or peripheral vascular diseases.
- Current or past history of cancer.
- Use of a hand or wrist splint within the past three months.
- Presence of an implanted pacemaker or electrical prosthesis.
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: The Treatment Group
Participants in this group will receive TECAR therapy at a frequency of 0.5 MHz and intensity of 30 to 50% and medium Capacitive Energy Transfer electrode (60 mm), 5 min capacitive (CAP) and 10 min resistive (RES), three sessions per week for two weeks plus standard post-burn hand rehabilitation
|
TECAR therapy at a frequency of 0.5 MHz and intensity of 30 to 50% and medium Capacitive Energy Transfer electrode (60 mm), 5 min capacitive (CAP) and 10 min resistive (RES), The passive electrode was fixed to the dorsum of the hand while the active electrode was moved in a circular manner from the proximal carpal tunnel to the median nerve pathway of the palm in three sessions per week for two weeks
US using a 3 MHz probe at a dose of 1.5 watts/cm2 for 5 min intermittently for 2 weeks, 5 times a week, plus mobility and strengthening exercises
|
|
Comparador activo: The Control Group
Participants in this arm will receive standard post-burn hand rehabilitation (e.g., Exercise, stretch, and US)
|
US using a 3 MHz probe at a dose of 1.5 watts/cm2 for 5 min intermittently for 2 weeks, 5 times a week, plus mobility and strengthening exercises
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Symptom Severity
Periodo de tiempo: Baseline and 2 weeks
|
The Arabic version of the BCTQ-SSS will be used to self-report symptom severity.
It consists of 11 items assessing pain, numbness, paresthesia, weakness, and nocturnal symptoms.
Each item is scored from 1 (never/none) to 5 (most severe).
The overall score is calculated as the mean of the items, ranging from 1 to 5, where higher scores indicate worse symptom severity.
|
Baseline and 2 weeks
|
|
Functional Status
Periodo de tiempo: Baseline and 2 weeks.
|
The Arabic version of the BCTQ-FSS will be used to evaluate hand function across 8 common activities.
Each activity is scored from 1 (no difficulty) to 5 (cannot perform the activity at all).
The total score is the mean of the items, ranging from 1 to 5, where higher scores represent greater functional impairment.
|
Baseline and 2 weeks.
|
|
Grip Strength
Periodo de tiempo: Baseline and 2 weeks.
|
Objective hand function and force production of the median nerve-innervated muscles will be measured using a Camry Digital Handgrip Dynamometer.
Measurements are recorded in kilograms (kg), up to a maximum strength of 90 kg.
Higher scores indicate greater hand grip strength.
|
Baseline and 2 weeks.
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Pain Intensity
Periodo de tiempo: Baseline and 2 weeks.
|
Pain intensity will be measured using the Arabic version of the VAS, where patients mark their current pain level on a 10-cm line.
The scale ranges from 0 cm ("no pain") to 10 cm ("worst pain").
Higher scores represent greater pain severity.
|
Baseline and 2 weeks.
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Investigadores
- Director de estudio: Wafaa Hussien Borhan, Professor, Cairo University
- Director de estudio: Ashraf Alsibai Mohamed, Professor, Cairo University
Publicaciones y enlaces útiles
La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.
Publicaciones Generales
- Chesterton LS, Blagojevic-Bucknall M, Burton C, Dziedzic KS, Davenport G, Jowett SM, Myers HL, Oppong R, Rathod-Mistry T, van der Windt DA, Hay EM, Roddy E. The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial. Lancet. 2018 Oct 20;392(10156):1423-1433. doi: 10.1016/S0140-6736(18)31572-1.
- Tashiro Y, Hasegawa S, Yokota Y, Nishiguchi S, Fukutani N, Shirooka H, Tasaka S, Matsushita T, Matsubara K, Nakayama Y, Sonoda T, Tsuboyama T, Aoyama T. Effect of Capacitive and Resistive electric transfer on haemoglobin saturation and tissue temperature. Int J Hyperthermia. 2017 Sep;33(6):696-702. doi: 10.1080/02656736.2017.1289252. Epub 2017 Feb 19.
- Yeste-Fabregat M, Baraja-Vegas L, Vicente-Mampel J, Perez-Bermejo M, Bautista Gonzalez IJ, Barrios C. Acute Effects of Tecar Therapy on Skin Temperature, Ankle Mobility and Hyperalgesia in Myofascial Pain Syndrome in Professional Basketball Players: A Pilot Study. Int J Environ Res Public Health. 2021 Aug 19;18(16):8756. doi: 10.3390/ijerph18168756.
- Vahdatpour, B., Ghasemi, H. R., & Taheri, P. (2023). Effectiveness of TECAR Therapy on Clinical Symptoms and Neurophysiological Parameters of Patients with Carpal Tunnel Syndrome: A Randomized Clinical Trial. Middle East Journal of Rehabilitation and Health Studies, 10(3). https://doi.org/10.5812/mejrh-134171
- Tezen O, Bilir EE, Uzun O, Yaniktas D, Senturk B, Yasar E. Evaluation of the efficacy of transfer energy capacitive and resistive therapy in patients with knee osteoarthritis. Turk J Med Sci. 2024 Oct 7;54(6):1302-1309. doi: 10.55730/1300-0144.5913. eCollection 2024.
- Tezen O, Ata AM, Uzun O, Cakir F, Yasar E. Comparison of the effectiveness of ultrasound and transfer energy capacitive and resistive (TECAR) therapy in patients with carpal tunnel syndrome. Lasers Med Sci. 2025 Mar 19;40(1):147. doi: 10.1007/s10103-025-04412-z.
- Szabo DA, Neagu N, Teodorescu S, Predescu C, Sopa IS, Panait L. TECAR Therapy Associated with High-Intensity Laser Therapy (Hilt) and Manual Therapy in the Treatment of Muscle Disorders: A Literature Review on the Theorised Effects Supporting Their Use. J Clin Med. 2022 Oct 19;11(20):6149. doi: 10.3390/jcm11206149.
- Rosario NB, De Jesus O. Electrodiagnostic Evaluation of Carpal Tunnel Syndrome. 2023 Aug 23. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK562235/
- Ribeiro, S., Henriques, B., & Cardoso, R. (2018). To cite this article Samuel Ribeiro, Bebiana Henriques, Ricardo Cardoso. The Effectiveness of Tecar Therapy in Musculoskeletal Disorders. In International Journal of Public Health and Health Systems (Vol. 3, Issue 5). http://www.openscienceonline.com/journal/ijphhs
- Niajalili M, Mohsen Roostayi M, Daryabor A, Naimi SS, Amoli MJ. The effect of Tecar therapy on neurological disorders and nerve conduction velocity of lower limbs in peripheral neuropathy of type 2 diabetic patients: A six-week follow-up study. Turk J Phys Med Rehabil. 2023 Oct 12;69(4):479-487. doi: 10.5606/tftrd.2023.11875. eCollection 2023 Dec.
- Mitie Ida, A., Borba Neves, E., & Wan Stadnik, A. M. (2023). Effects of Tecartherapy on Body Tissue: A Systematic Review. Journal of Biomedical Science and Engineering, 16(10), 133-148. https://doi.org/10.4236/jbise.2023.1610010
- Mahran, H. G., Mohammed, A. H., & Aboelazm, S. N. (2015). EXTRACORPOREAL SHOCKWAVE THERAPY FOR POST BURN CARPAL TUNNEL SYNDROME. International Journal of Physiotherapy and Research, 3(2), 938-946. https://doi.org/10.16965/ijpr.2015.111
- Lupton-Smith A, Fourie K, Mazinyo A, Mokone M, Nxaba S, Morrow B. Measurement of hand grip strength: A cross-sectional study of two dynamometry devices. S Afr J Physiother. 2022 Sep 26;78(1):1768. doi: 10.4102/sajp.v78i1.1768. eCollection 2022.
- Lupowitz LG, Ramus L, Delacour F, Johnson K. TECAR Therapy: A Clinical Commentary on its Evolution, Application, and Future in Rehabilitation. Int J Sports Phys Ther. 2025 Apr 1;20(4):632-640. doi: 10.26603/001c.130909. eCollection 2025.
- Diagne, N., Tonga, M., Seye, M., Sy, A., Mboup, D., Guèye, A., Sakho, M., Lo, P., Seck, L., Fall, M., Ndiaye, M., & Diop, A. (2024). Grip Strength and Carpal Tunnel: What Interest in Management. Journal of Physical Medicine, 5(1). https://doi.org/10.36959/942/347
- Cao, J., Jia, T., Lao, J., Liu, A., & Rui, J. (2022). Evaluation of different physical examination methods for the diagnosis of carpal tunnel syndrome. World Academy of Sciences Journal, 4(5), 33. https://doi.org/10.3892/wasj.2022.168
- Alanazy MH. Clinical and electrophysiological evaluation of carpal tunnel syndrome: approach and pitfalls. Neurosciences (Riyadh). 2017 Jul;22(3):169-180. doi: 10.17712/nsj.2017.3.20160638.
- Albert T, Perrot P, Lecoq FA, Lancien U. Post-burn carpal tunnel syndrome: A systematic review. Hand Surg Rehabil. 2025 Jun;44(3):102134. doi: 10.1016/j.hansur.2025.102134. Epub 2025 Mar 22.
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Estimado)
16 de junio de 2026
Finalización primaria (Estimado)
30 de octubre de 2026
Finalización del estudio (Estimado)
1 de diciembre de 2026
Fechas de registro del estudio
Enviado por primera vez
16 de junio de 2026
Primero enviado que cumplió con los criterios de control de calidad
16 de junio de 2026
Publicado por primera vez (Actual)
22 de junio de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
22 de junio de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
16 de junio de 2026
Última verificación
1 de junio de 2026
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- TECAR on post burn CTS
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
NO
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .